Home Ampersand Biomedicines

Ampersand Biomedicines

In operation
Series B
Next-Generation Modular Drug Developer
Basic
Enterprise Profile

Basic Information

Ampersand Biomedicines Offers a New Approach to Designing Programmable Drugs That Work Precisely Where Needed in the Body, and Nowhere Else. The company's most advanced computational-driven Address, Navigate, Design (AND)™ platform continuously learns the rules for identifying optimal locator targets and refines its ability to design within the complex space of locators and actuators. The result is increasingly sophisticated AND-body™ therapies, which are engineered beyond the physical limitations of molecules and the biological characteristics of targets to effectively target disease sites without affecting healthy tissues or cells.
Ampersand Biomedicines
--
15~50 people
January 01, 2020
info@ampersand.bio

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Targeted Technology
Concept
Disease Treatment
Application Scenarios
Chemical Drug Targeted drugs Innovative Drugs AI+Pharmaceuticals